World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
90
Citations
47939
World Ranking
2384
National Ranking
1268

Anthony Letai publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Anthony Letai sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 380 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Anthony Letai D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony Letai sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 90 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Anthony Letai is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Molecular Biology, Hematology, Oncology, Genetics, and Immunology.

The researcher's work focuses on various specialized topics, including:

  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research
  • Histone Deacetylase Inhibitors Research
  • Multiple Myeloma Research and Treatments

Anthony Letai has published extensively in several scientific journals. Most frequent publication venues include:

  • Blood
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood Advances
  • Leukemia

Significant recent papers authored or co-authored by Anthony Letai demonstrate a focus on cancer research, particularly leukemia and precision oncology:

  • "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia," 2020, New England Journal of Medicine
  • "Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations," 2021, Cancer Cell
  • "Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis," 2022, Cell
  • "Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study," 2020, American Journal of Hematology
  • "Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia," 2020, Cancer Cell

The research network of Anthony Letai includes frequent collaboration with several co-authors:

  • Jeremy Ryan
  • Jacqueline S. Garcia
  • Shruti Bhatt
  • Daniel J. DeAngelo
  • Marlise R. Luskin

Anthony Letai is recognized as a member of the Association of American Physicians.

Best Publications

  • The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

  • An inhibitor of Bcl-2 family proteins induces regression of solid tumours

    Tilman Oltersdorf;Steven W. Elmore;Alexander R. Shoemaker;Robert C. Armstrong

  • Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

    Anthony Letai;Michael C. Bassik;Loren D. Walensky;Mia D. Sorcinelli

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

    Rumani Singh;Anthony Letai;Kristopher Sarosiek

  • Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.

    Courtney D. DiNardo;Keith Pratz;Vinod Pullarkat;Brian A. Jonas

  • Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.

    Michael Certo;Victoria Del Gaizo Moore;Mari Nishino;Guo Wei

  • Control of mitochondrial apoptosis by the Bcl-2 family.

    Joslyn K. Brunelle;Anthony Letai

  • Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1

    Joseph T. Opferman;Anthony Letai;Caroline Beard;Mia D. Sorcinelli

  • Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

    Marina Konopleva;Daniel A. Pollyea;Jalaja Potluri;Brenda Chyla

  • A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

    Dharminder Chauhan;Laurence Catley;Guilan Li;Klaus Podar

  • Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

    Courtney D DiNardo;Keith W Pratz;Anthony Letai;Brian A Jonas

  • Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737

    Victoria Del Gaizo Moore;Jennifer R. Brown;Michael Certo;Tara M. Love

  • Diagnosing and exploiting cancer's addiction to blocks in apoptosis

    Anthony G. Letai

  • Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    Rongqing Pan;Leah J. Hogdal;Juliana M. Benito;Donna Bucci

  • Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

    Triona Ni Chonghaile;Kristopher A. Sarosiek;Thanh Trang Vo;Jeremy A. Ryan

  • BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.

    Jing Deng;Nicole Carlson;Kunihiko Takeyama;Paola Dal Cin

  • Precision medicine for cancer with next-generation functional diagnostics

    Adam A. Friedman;Anthony Letai;David E. Fisher;Keith T. Flaherty

  • Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

    Jennifer L. Guerriero;Alaba Sotayo;Holly E. Ponichtera;Jessica A. Castrillon

  • Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.

    Derek Yecies;Nicole E. Carlson;Jing Deng;Anthony Letai

Frequent Co-Authors

Richard Stone
Richard Stone Harvard University
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Daniel J. DeAngelo
Daniel J. DeAngelo Harvard University
Donna Neuberg
Donna Neuberg Harvard University
Jennifer R. Brown
Jennifer R. Brown Harvard University
Benjamin L. Ebert
Benjamin L. Ebert Harvard University
Stephen E. Sallan
Stephen E. Sallan Harvard University
Catherine J. Wu
Catherine J. Wu Harvard University
Gad Getz
Gad Getz Broad Institute
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Anthony Letai

Trending Scientists

Recently Published Articles